참고문헌
- Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci 2011;48:155-70. https://doi.org/10.3109/10408363.2011.599831
- Caraceni A, Nanni O, Maltoni M, Piva L, Indelli M, Arnoldi E, et al. Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative Care. Cancer 2000;89:1145-9. https://doi.org/10.1002/1097-0142(20000901)89:5<1145::AID-CNCR24>3.0.CO;2-X
- Ho F, Lau F, Downing MG, Lesperance M. A reliability and validity study of the Palliative Performance Scale. BMC Palliat Care 2008;7:10. https://doi.org/10.1186/1472-684X-7-10
- Kersten C, Louhimo J, Algars A, Lahdesmaki A, Cvancerova M, Stenstedt K, et al. Increased C-reactive protein implies a poorer stage-specific prognosis in colon cancer. Acta Oncol 2013; 52:1691-8. https://doi.org/10.3109/0284186X.2013.835494
- Lee SY, Lee YJ, Yang JH, Kim CM, Choi WS. The Association between Phase Angle of Bioelectrical Impedance Analysis and Survival Time in Advanced Cancer Patients: Preliminary Study. Korean J Fam Med 2014;35:251-6. https://doi.org/10.4082/kjfm.2014.35.5.251
- Lee YJ, Suh SY, Choi YS, Shim JY, Seo AR, Choi SE, et al. EORTC QLQ-C15-PAL quality of life score as a prognostic indicator of survival in patients with far advanced cancer. Support Care Cancer 2014;22:1941-8. https://doi.org/10.1007/s00520-014-2173-8
- Morita T, Tsunoda J, Inoue S, Chihara S. Validity of the palliative performance scale from a survival perspective. J Pain Symptom Manage 1999;18:2-3. https://doi.org/10.1016/S0885-3924(99)00040-8
- Suh SY, Choi YS, Yeom CH, Kwak SM, Yoon HM, Kim DG, et al. Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer. Supportive Care in Cancer 2013;21:3071-7. https://doi.org/10.1007/s00520-013-1878-4
- Yoon J, Ahn SH, Lee YJ, Kim CM. Hyponatremia as an independent prognostic factor in patients with terminal cancer. Support Care Cancer 2015;23:1735-40. https://doi.org/10.1007/s00520-014-2522-7
- Anderson F, Downing GM, Hill J, Casorso L, Lerch N. Palliative performance scale (PPS): a new tool. J Palliat Care 1996;12:5-11.
- Downing M, Lau F, Lesperance M, Karlson N, Shaw J, Kuziemsky C, et al. Meta-analysis of survival prediction with Palliative Performance Scale. J Palliat Care 2007;23:245-52; discussion 252-4.
- Lau F, Bell H, Dean M, Downing M, Lesperance M. Use of the Palliative Performance Scale in survival prediction for terminally ill patients in Western Newfoundland, Canada. J Palliat Care 2008;24:282-4.
- Lau F, Downing M, Lesperance M, Karlson N, Kuziemsky C, Yang J. Using the Palliative Performance Scale to provide meaningful survival estimates. J Pain Symptom Manage 2009;38:134-44. https://doi.org/10.1016/j.jpainsymman.2008.05.017
- Myers J, Kim A, Flanagan J, Selby D. Palliative performance scale and survival among outpatients with advanced cancer. Support Care Cancer 2015;23:913-8. https://doi.org/10.1007/s00520-014-2440-8
- Weng LC, Huang HL, Wilkie DJ, Hoenig NA, Suarez ML, Marschke M, et al. Predicting survival with the Palliative Performance Scale in a minority-serving hospice and palliative care program. J Pain Symptom Manage 2009;37:642-8. https://doi.org/10.1016/j.jpainsymman.2008.03.023
- Chan EY, Wu HY, Chan YH. Revisiting the Palliative Performance Scale: change in scores during disease trajectory predicts survival. Palliat Med 2013;27:367-74. https://doi.org/10.1177/0269216312451613
- Lau F, Downing GM, Lesperance M, Shaw J, Kuziemsky C. Use of Palliative Performance Scale in end-of-life prognostication. J Palliat Med 2006;9:1066-75. https://doi.org/10.1089/jpm.2006.9.1066
- Baek YJ, Shin DW, Choi JY, Kang J, Mo HN, Kim YH, et al. Late referral to palliative care services in Korea. J Pain Symptom Manage 2011;41:692-9. https://doi.org/10.1016/j.jpainsymman.2010.06.019
- Lee YJ, Yang JH, Lee JW, Yoon J, Nah JR, Choi WS, et al. Association between the duration of palliative care service and survival in terminal cancer patients. Support Care Cancer 2015;23:1057-62. https://doi.org/10.1007/s00520-014-2444-4
- Arai Y, Okajima Y, Kotani K, Tamba K. Prognostication based on the change in the palliative prognostic index for patients with terminal cancer. J Pain Symptom Manage 2014;47:742-7. https://doi.org/10.1016/j.jpainsymman.2013.05.011
- Kao CY, Hung YS, Wang HM, Chen JS, Chin TL, Lu CY, et al. Combination of initial palliative prognostic index and score change provides a better prognostic value for terminally ill cancer patients: a six-year observational cohort study. J Pain Symptom Manage 2014;48:804-14. https://doi.org/10.1016/j.jpainsymman.2013.12.246
- Peng MT, Liu CT, Hung YS, Kao CY, Chang PH, Yeh KY, et al. Sequential Assessments of the Eastern Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. Am J Hosp Palliat Care 2016;33:471-6. https://doi.org/10.1177/1049909114566226
- Seow H, Barbera L, Dudgeon D, Howell D, Husain A, Atzema C, et al. The association of the palliative performance scale and hazard of death in an ambulatory cancer population. J Palliat Med 2013;16:156-62. https://doi.org/10.1089/jpm.2012.0239
- Flume PA. Medicinal treatment of intractable dyspnea in terminally ill patients. J S C Med Assoc 2002;98:196-9.
- Hilliard N, Brown S, Mitchinson S. A case report of dexmedetomidine used to treat intractable pain and delirium in a tertiary palliative care unit. Palliat Med 2015;29:278-81. https://doi.org/10.1177/0269216314556923
- Strand JJ, Feely MA, Kramer NM, Moeschler SM, Swetz KM. Palliative Sedation and What Constitutes Active Dying: A Case of Severe Progressive Dystonia and Intractable Pain. Am J Hosp Palliat Care 2016;33:363-8. https://doi.org/10.1177/1049909114561997
- Watson PN, Evans RJ. Intractable pain with lung cancer. Pain 1987;29:163-73. https://doi.org/10.1016/0304-3959(87)91033-5
- Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Buchler MW, Friess H, Martignoni ME. Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 2008;12:1193-201. https://doi.org/10.1007/s11605-008-0505-z
- Gioulbasanis I, Georgoulias P, Vlachostergios PJ, Baracos V, Ghosh S, Giannousi Z, et al. Mini Nutritional Assessment (MNA) and biochemical markers of cachexia in metastatic lung cancer patients: interrelations and associations with prognosis. Lung Cancer 2011;74:516-20. https://doi.org/10.1016/j.lungcan.2011.05.009
- Jin C, Li J, Wang Y, Chen X, Che Y, Liu X, et al. Impact of cellular immune function on prognosis of lung cancer patients after cytokine-induced killer cell therapy. Asian Pac J Cancer Prev 2014;15:6009-14. https://doi.org/10.7314/APJCP.2014.15.15.6009
- Kimura M, Naito T, Kenmotsu H, Taira T, Wakuda K, Oyakawa T, et al. Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer. Support Care Cancer 2015;23:1699-708. https://doi.org/10.1007/s00520-014-2534-3
- Kimura T, Kamiura S, Yamamoto T, Seino-Noda H, Ohira H, Saji F. Abnormal uterine bleeding and prognosis of endometrial cancer. Int J Gynaecol Obstet 2004;85:145-50. https://doi.org/10.1016/j.ijgo.2003.12.001
- Li Y, Jin ZC, Cai Y, Ji MS, Liu J. Value of serum procalcitonin in evaluating the prognosis of sepsis in elderly patients with colorectal cancer undergoing emergency colorectal surgery. Indian J Surg 2013;75:86-93.
- Wang J, Zhou W, Xu L, Yang M, Meng L, Fan W, et al. Risk factors and prognosis of lung cancer combined with pulmonary embolism. Zhongguo Fei Ai Za Zhi 2011;14:780-4.
- Wu D, Tao J, Ding J, Qu P, Lu Q, Zhang W. Interleukin-11, an interleukin-6-like cytokine, is a promising predictor for bladder cancer prognosis. Mol Med Rep 2013;7:684-8. https://doi.org/10.3892/mmr.2012.1199
- Yoshitomi M, Yutani S, Matsueda S, Ioji T, Komatsu N, Shichijo S, et al. Personalized peptide vaccination for advanced biliary tract cancer: IL-6, nutritional status and pre-existing antigen-specific immunity as possible biomarkers for patient prognosis. Exp Ther Med 2013;3:463-9.
- Peng M, Liu C, Hung Y, Kao C, Chang P, Yeh K, et al. Sequential Assessments of the Eastern Cooperative Oncology Group Performance Scale Enhance Prognostic Value in Patients With Terminally Ill Cancer Receiving Palliative Care. Am J Hosp Palliat Care 2016;33:471-6. https://doi.org/10.1177/1049909114566226
- Alsirafy SA, Sroor MY, Al-Shahri MZ. Predictive impact of electrolyte abnormalities on the admission outcome and survival of palliative care cancer referrals. J Palliat Med 2009;12:177-80. https://doi.org/10.1089/jpm.2008.0200
- Glare P. Clinical predictors of survival in advanced cancer. J Support Oncol 2005;3:331-9.
- Vigano A, Bruera E, Jhangri GS, Newman SC, Fields AL, Suarez-Almazor ME. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000;160:861-8. https://doi.org/10.1001/archinte.160.6.861